ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.180
+0.030 (1.40%)
At close: Jan 22, 2026, 4:00 PM EST
2.220
+0.040 (1.83%)
After-hours: Jan 22, 2026, 6:12 PM EST
ProKidney Market Cap
ProKidney has a market cap or net worth of $655.82 million as of January 22, 2026. Its market cap has increased by 175.53% in one year.
Market Cap
655.82M
Enterprise Value
412.40M
1-Year Change
175.53%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $50.55M to $655.82M, an increase of 1,197.37%. That is a compound annual growth rate of 75.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 304.32M | -4.02% |
| Dec 31, 2025 | 317.06M | 46.61% |
| Dec 31, 2024 | 216.27M | 80.97% |
| Dec 29, 2023 | 119.50M | -71.69% |
| Dec 30, 2022 | 422.17M | 33.72% |
| Dec 31, 2021 | 315.71M | 524.55% |
| Jun 30, 2021 | 50.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 700.06M |
| Fulcrum Therapeutics | 687.41M |
| Cullinan Therapeutics | 685.28M |
| Rigel Pharmaceuticals | 683.22M |
| Gossamer Bio | 634.19M |
| Tenax Therapeutics | 630.87M |
| enGene Holdings | 625.64M |
| Invivyd | 623.19M |